PSP Research »

Alkermes shares owned by PSP Research

Quarter-by-quarter ownership of Alkermes (ALKS) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Alkermes

Tip: Access up to 7 years of quarterly data

All positions including Alkermes held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alkermes by PSP Research

Quarter filed Position value Share count Share price at filing
2025-12-31 $540k 19k 27.98

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Praxis Precision Medicines I Com New (PRAX)
Travere Therapeutics (TVTX)
Tyra Biosciences (TYRA)
Pharvaris N V (PHVS)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Celldex Therapeutics Com New (CLDX)
Cg Oncology (CGON)
Belite Bio Sponsored Ads (BLTE)
Ascendis Pharma A/s Sponsored Adr (ASND)
Apellis Pharmaceuticals (APLS)
Terns Pharmaceuticals (TERN)
Revolution Medicines (RVMD)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Bridgebio Pharma (BBIO)

View all positions for PSP Research

Top funds holding Alkermes

BlackRock
Vanguard Group
Baker Bros. Advisors
State Street Corporation
Renaissance Technologies
American Century Companies
Dimensional Fund Advisors
Geode Capital Management
Commodore Capital
Wellington Management Company
PRIMECAP Management Company
UBS Group
Nuveen
Goldman Sachs Group
Charles Schwab Investment Management

View all funds holding Alkermes